Showing 1591-1600 of 2884 results for "".
- Congrats: Dr. Corey S. Maas Named New AAFPRS Presidenthttps://modernaesthetics.com/news/congrats-dr-corey-s-maas-named-new-aafprs-president/2473155/Corey S. Maas, MD is the new president of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). Dr. Mass, the founder of The Maas Clinic in San Francisco, will serve the 2021 to 2022 year term Dr. Maas is certified
- Cynosure Launches Potenza™ RF Microneedling System with New Fusion Tip™ in Canadahttps://modernaesthetics.com/news/cynosure-launches-potenza-rf-microneedling-system-with-new-fusion-tip-in-canada/2473149/Health Canada has cleared Cynosure’s Potenza™ radiofrequency (RF) microneedling system, offering clinicians versatility and personalized treatments for patients with the system's one-of-a-kind Fusion
- ellacor Maker Cytrellis Closes Funding Roundhttps://modernaesthetics.com/news/ellacor-maker-cytrellis-closes-funding-round/2473145/Cytrellis has closed a $50 million Series C funding round. The financing was led by D1 Capital Partners and included participation from an additional new investor, Sands Capital, as well as existing institutional investors, ARCH Venture Partners and PFM Health Sciences. Proceeds will be
- It’s Over: AbbVie, BTL Settle Muscle Stimulation Patent Disputehttps://modernaesthetics.com/news/its-over-abbvie-btl-settle-patent-dispute/2473143/BTL Industries has resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the terms of the settlement agreement, AbbVie will pay BTL an undisclosed payment. The details of the agreement are confidential and will not be disc
- Sientra’s Allox2 Helps Manage Seroma and Infection in Prepectoral Breast Reconstructionhttps://modernaesthetics.com/news/sientras-allox2s-helps-manage-seroma-and-infection-in-prepectoral-breast-reconstruction/2473138/The Sientra Allox2 dual port tissue expander enables efficient management of seroma and early targeted intervention in prepectoral breast reconstruction, according to a new study on PRS Global Open. Seroma are among the most common complications after staged prepectoral implant
- Sciton Launches mJOULE in Canadahttps://modernaesthetics.com/news/sciton-launches-mjoule-in-canada/2473136/Sciton Inc. is launching the new mJOULE platform in Canada. This system features the company's newest fractional treatment MOXI and BBL HERO treatment. "Part of Sciton's global growth strategy is to ensure our partners and their
- As Aging Population Increases, Medical Aesthetics Market is Predicted to Growhttps://modernaesthetics.com/news/as-aging-population-increases-medical-aesthetics-market-is-predicted-to-grow/2473135/The global Medical Aesthetics Market, valued at USD 10.1 billion in 2018, is expected to reach USD 20.4 billion in 2026, growing at a CAGR of 9.0% during the forecast period, according to the latest report from All
- Kate Beckinsale Joins MRVL as the Face of its Anti-Aging Skin Care Linehttps://modernaesthetics.com/news/kate-beckinsale-joins-mrvl-as-the-face-of-its-anti-aging-skin-care-line-mrvl-skin-solutions/2473132/Kate Beckinsale is the face of MRVL Skin Solutions, an anti-aging skincare line launching this Fall. MRVL Skin Solutions is based on a novel ingredient in anti-aging: a Blue Scorpion Peptide. This peptide helps stimulate natural collagen production, fights free radicals, helps rege
- San Francisco Plastic Surgery Practice Mandates Vaccines for Staff and Patientshttps://modernaesthetics.com/news/san-francisco-plastic-surgery-practice-mandates-vaccines-for-staff-and-patients/2473131/Jonathan Kaplan, MD has instituted a new policy for his Pacific Heights Plastic Surgery practice in San Francisco. All staff and patients are now required to have had the COVID-19 vaccine to enter the practice. As was recently reported in
- Bausch Health Pursues IPO of Solta Medicalhttps://modernaesthetics.com/news/bausch-health-pursues-ipo-of-solta-medical/2473130/Bausch Health Companies Inc. is planning to pursue an initial public offering (IPO) of its Solta Medical business. Solta’s portfolio includes the Thermage RF systems, Fraxel laser, Clear + Brilliant laser and VASER ultrasonic systems. The timing of the anticipated IPO, w